search for




 

Instructions to Authors



  • GENERAL CONSIDERATIONS
    Journal of Oral Medicine and Pain (JOMP) is an official publication of the Korean Academy of Orofacial Pain and Oral Medicine. Journal of Oral Medicine and Pain abbreviated in accordance with the style of Index Medicus is J Oral Med Pain. It is published four times per year on the 30th day of March, June, September, and December. The journal publishes original articles, case reports, brief communications, letters to the editor, announcements, editorials, and review articles in the fields of oral medicine, orofacial pain, and forensic odontology. Submissions are accepted only on the understanding that they have not been submitted elsewhere and have not been published elsewhere. Its editorial policies are the responsibility of the Editor-in-Chief, the associated editors, and the Editorial Board under the general authority of the Editorial Committee.
    All submitted papers are peer-reviewed before it is decided whether they should be accepted, rejected, or returned for revision. Authors should follow the guidelines below. Proofs will be sent to the corresponding author for final approval. Accepted manuscripts become the permanent property of this journal and may not be reproduced by any means, in whole or in part without the written permission of the publisher.
    Any sumbmission listing adolescent who does not belong to an academic affiliation as author(s) should include a documentation about the final affiliation, title, and year of enrollment. The submitted document should be kept separately by the editorial board.
    The editorial board should review whether the adolescent author has made a vaild academic contribution to the submitted paper prior to the assignment of reviewers.
    Following is the contact information for your reference.


  • Editorial Office
    Journal of Oral Medicine and Pain
    Department of Orofacial Pain and Oral Medicine, School of Dentistry, Dankook University, 119 Dandae-ro, Dongnam-gu, Cheonan 31116, Korea
    Tel: +82-41-550-1913
    Fax: +82-41-553-7169
    E-mail: office@journalomp.org
    Website: http://www.journalomp.org


  • EDITORIAL POLICY
    1. Ethical Guidelines

    JOMP adheres to the ethical guidelines for research and publication described in Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals' (http://www.icmje.org/recommendations/; International Committee of Medical Journal Editors [ICMJE]), 'Good Publication Practice Guidelines for Medical Journals' (https://www.kamje.or.kr/board/view?b_name=bo_publication&bo_id=13&per_page=; Korean Association of Medical Journal Editors [KAMJE]), and 'Guidelines on Good Publication' (http://publicationethics.org/resources/flowcharts; Committee on Publication Ethics [COPE]). For the policies on the research and publication ethics not stated in this instructions, international standards for editors and authors (https://publicationethics.org/resources/resources-and-further-reading/international-standards-editors-and-authors) can be applied.


    2. Informed Consent

    Human study must conform to ethical standards, and be approved by the appropriate Institutional Review Board (IRB). A statement concerning IRB approval and consent procedures must appear at the beginning of the Materials and Methods section. Any systematic data gathering effort in patients or volunteers must be approved by an IRB or adhere to appropriate local/national regulations. Authors may be questioned about the details of consent forms or the consent process. On occasion, the Editor-in-Chief may request a copy of the approved IRB application from the author.


    3. Registration of the Clinical Research and Data Sharing Policy

    Any research that deals with clinical trial should be registered to the primary national clinical trial registration site such as http://cris.nih.go.kr/cris/index.jsp, or other sites accredited by World Health Organization or ICMJE (http://www.icmje.org/).
    This journal follows the data sharing policy described in "Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors". The ICMJE's policy regarding trial registration is explained at https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record.




  • RESEARCH AND PUBLICATION ETHICS

    The journal adheres to the guidelines and best practices published by professional organizations, including ICMJE Recommendations and the Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by the COPE; the Directory of Open Access Journals; the World Association of Medical Editors; and Open Access Scholarly Publishers Association; http://doaj.org/bestpractice). Furthermore, the full process of handling research and publication misconduct should follow the COPE flowchart (http://publicationethics.org/resources/flowcharts). Any attempt to duplicate publication or any plagiarism will lead to rejection by decision of the editorial board. It may prejudice the acceptance of future submissions, and may be highlighted within the pages of the journal.


    1. Authorship and Author's Responsibility

    Authorship confers credit and has important academic, social, and financial implications. Authorship also implies responsibility and accountability for published work. According to the ICMJE recommendation, authorship is based on the following four criteria: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or reviewing it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet all four criteria.
    Contributors who meet fewer than all four of the above criteria for authorship should not be listed as authors, but they should be acknowledged. Examples of activities that alone (without other contributions) do not qualify a contributor for authorship are acquisition of funding; general supervision of a research group or general administrative support; and writing assistance, technical editing, language editing, and proofreading.
    JOMP dose not allow multiple corresponding authors for one article. Only one author should correspond with the editorial office. When the study was clearly performed by co-first authors, JOMP will accept a notice of equal contribution for the first author. For a case report and review article, JOMP allows only one first author.
    After the initial submission of a manuscript, any change in authorship (adding author(s), deleting author(s), or rearranging the order of authors) is not generally accepted, but must be explained by a letter to the editor from the authors concerned if it is absolutely necessary. This letter must be signed by all authors of the paper. JOMP does not correct authorship after acceptance for publication unless a mistake has been made by the editorial staff.
    Generative AI including language models, chatbots, image creators, machine learning, or similar technologies do not qualify for authorship. The technologies listed above may be used in enhancing readability and language accuracy in scientific writing. The responsibility for the manuscript’s integrity ultimately rests with the human authors, and the authors employing generative AI tools in manuscript preparation are required to disclose their use in the acknowledgements section. Such disclosure should detail the specific tools used, including the model name, version, and manufacturer, and explain the capacity in which they were employed. Should the use of AI extend beyond language enhancement, the methods and tools used must be detailed in the Materials and Methods section as a formal part of the research design.


    2. Originality and Duplicate Publication

    All submitted manuscripts should be original and should not be considered by other scientific journals for publication at the same time. No part of the accepted manuscript should be duplicated in another scientific journal without permission by Editorial Board. If duplicate publications related to the papers of this journal are detected, the publication of the papers can be disapproved in JOMP based on the decision of the Research Ethics Committee of JOMP. The journal follows the COPE Flowcharts (http://publicationethics.org/resources/flowcharts) for resolving cases of suspected misconduct.


    3. Conflict-of-Interest Statement

    All participants in the publication and peer review process—not only authors but also peer reviewers, editors, and editorial board members of journals—must consider their conflicts of interest when fulfilling their roles in the process of article review and publication and must disclose all relationships that could be viewed as potential conflicts of interest. Conflict of interest exists when professional judgment concerning a primary interest (such as patients' welfare or the validity of research) may be influenced by a secondary interest (such as financial gain). Conflict of interest also exists when an author (or the author's institution), reviewer, or editor has financial or personal relationships that inappropriately influence his/her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties).
    All authors should disclose their conflicts of interest, i.e., (1) financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony), (2) personal relationship, (3) academic competition, and (4) intellectual passion.
    These conflicts of interest must be included as a footnote on the title page. Each author should certify the disclosure of any conflict of interest with his/her signature. Peer reviewers must disclose to editors any conflicts of interest that could bias their opinions of the manuscript, and should recuse themselves from reviewing specific manuscripts if the potential for bias exists. Editors who make final decisions about manuscripts should recuse themselves from editorial decisions if they have conflicts of interest or relationships that pose potential conflicts related to articles under consideration. Other editorial staff members who participate in editorial decisions must provide editors with a current description of their financial interests or other conflicts (as they might relate to editorial judgments) and recuse themselves from any decisions in which a conflict of interest exists. Further guidance is available from COPE (http://publicationethics.org/files/A_Short_Guide_to_Ethical_Editing.pdf) and WAME (http://wame.org/conflictof-interest-in-peerreviewed-medical-journals). If undisclosed conflict of interest is suspected in a submitted manuscript or published article, a committee composed of Editorial Board members will be held and discussed, and JOMP will follow the process of the applicable COPE flowchart (http://publicationethics.org/resources/flowcharts).


    4. Statement of Human and Animal Rights

    Clinical research studies must state that the work was done in accordance with the Ethical Principles for Medical Research Involving Human Subjects outlined in the Helsinki Declaration in 1975 (revised in 2013; https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). Clinical studies that do not meet the Helsinki Declaration will not be considered for publication. Human subjects must not be identifiable. Patients' name, initial, hospital number, date of birth, or other protected healthcare information must not be disclosed. Animal research studies must state that the work was performed according to National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals must be observed.


    5. Statement of Informed Consent and IRB/IACUC Approval

    Copies of written informed consent and IRB/Institutional Animal Care and Use Committee (IACUC) approval for clinical research should be kept. If necessary, the editor or reviewers may request copies of these documents to resolve questions about IRB/IACUC approval and study conduct. In the case of a case report, an approval of IRB or a letter of exemption from deliberation is required.


    6. Management Procedures for the Research and Publication Misconduct

    When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, a fraudulent undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author's idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the Editorial Board.


    7. Editorial Responsibilities

    The Editorial Board will continuously work to monitor and safeguard publication ethics: guidelines for retracting articles; maintenance of the integrity of the academic record; preclusion of business needs from compromising intellectual and ethical standards; publishing corrections, clarifications, retractions, and apologies when needed; and excluding plagiarism and fraudulent data. The editors maintain the following responsibilities: responsibility and authority to reject and accept articles; avoiding any conflict of interest with respect to articles they reject or accept; promoting publication of corrections or retractions when errors are found; and preservation of the anonymity of reviewers.



  • PEER REVIEW POLICY
    1. Peer Review Policy and Process

    All papers, including those invited by the Editor, are subject to peer review. If the manuscript does not fit the aims and scope of JOMP or does not adhere to the Instructions for Authors, it may be returned to the author immediately after submission without review. For double-blind peer review, be sure manuscript cannot have any information which can identify the author. Authors' names or affiliations can be described in only title page. Submitted manuscripts are screened for possible plagiarism or duplicate publication by Similarity Check upon arrival. The title page will remain separate from the manuscript throughout the peer review process and will not be sent to the reviewers. The manuscript should be anonymized. Please make sure that any identifying information, such as authors' names or affiliations, is removed from your manuscript before submission.
    After screening, a manuscript is sent to the most three relevant reviewers of the field. In addition, if deemed necessary, a review of statistics may be requested. The Journal recommends peer reviewers to follow JOMP Review Regulations or the COPE Ethical Guidelines for Peer Reviewers (https://publicationethics.org/resources/guidelines/cope-ethical-guidelines-peer-reviewers).


    2. Editorial Decision

    Authors' names and affiliations are removed during peer review. The acceptance criteria for all papers are based on the quality and originality of the research and its clinical and scientific significance. Acceptance of the manuscript is decided based on the critiques and recommended decision of the reviewers. An initial decision will normally be made within 2-3 weeks of receipt of a manuscript, and reviewers' comments are sent to the first or corresponding authors by e-mail. Revised manuscripts must be submitted online by the first or corresponding author who must indicate the alterations that have been made in response to the reviewers' comments item by item. Failure to resubmit the revised manuscript within 8 weeks of the editorial decision is regarded as a withdrawal. A final decision on acceptance for publication or rejection for publication is forwarded to the first or corresponding author from the Editorial Office.
    Editorial decision such as acceptance, rejection, or request for revision will be notified to the corresponding author.


    3. Policy for Submissions by Members of the Editorial Team

    As all editors and Editorial Board members at the JOMP are active professionals and researchers, it may happen that they would want to submit their articles to the JOMP. This represents a potential conflict of interest, especially in cases of submissions from decision-making editors. In reviewing submissions from its editors and Editorial Board members, the JOMP follows the guidelines for good editorial practice set by international editorial organizations, such as World Association of Medical Editors (WAME; http://www.wame.org/resources/publication-ethics-policies-for-medicaljournals#conflicts) and Committee on Publication Ethics (COPE; https://publicationethics.org/case/editor-author-own-journal). The review of such manuscripts will be processed same to other unsolicited manuscripts. During the review process, submitters will not engage in the selection of reviewers and decision process. Editors will not handle their own manuscripts although they are commissioned ones.


  • APPEALS OF DECISIONS
    Any appeal against an editorial decision must be made within 2 weeks of the date of the decision letter. Authors who wish to appeal against a decision should contact the editor-in-chief, explaining in detail the reasons for the appeal. All appeals will be discussed with at least one other associate editor. If consensus cannot be reached thereby, an appeal will be discussed at a full editorial meeting. The process of handling complaints and appeals follows the guidelines of COPE available from (http://publicationethics.org/appeals). JOMP does not consider second appeals.


  • COPYRIGHT POLICY
    In view of copyright laws, accepted papers must complete the assignment forms. Copyrights of all published materials are owned by the Korean Academy of Orofacial Pain and Oral Medicine. These forms are available on the website (http://www.journalomp.org) and in the published journal. Once the form is signed by the authors, it should be scanned digitally and be sent to the editorial office. The papers will not be published until the copyright is completed.


  • DATA ARCHIVING POLICY
    Full text of JOMP has been archived in Korea Citation Index (http://www.kci.go.kr/kciportal/main.kci) and National Library of Korea (http://seoji.nl.go.kr/archive). JOMP provides the electronic backup and preservation of access to the journal content in the event the journal is no longer published by archiving in Korea Citation Index and National Library of Korea.


  • DATA SHARING POLICY
    JOMP encourages data sharing wherever possible, unless this is prevented by ethical, privacy, or confidentiality matters. Authors wishing to do so may deposit their data in a publicly accessible repository and include a link to the DOI within the text of the manuscript. The Journal accepts the ICMJE Recommendations for data sharing statement policy (http://icmje.org/icmje-recommendations.pdf). Authors may refer to the editorial, "Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors," in J Korean Med Sci 2017;32(7):1051-1053 (http://doi.org/10.3346/jkms.2017.32.7.1051).


  • SUBMISSION
    Manuscripts may be submitted via online through the website (http://www.journalomp.org). JOMP uses an online submission and review system. Authors who are unable to submit online should contact the Editorial Office.


  • COVER LETTER
    Cover letter should inform the editor that neither the submitted material nor portions thereof have been published previously or are under consideration for publication elsewhere. When more than one related manuscript has been published or is under consideration for publication by this or other journals, authors are required to declare this in their letter and to enclose copies of those publications for an editorial perusal. Failure to do so may lead to automatic rejection of the submitted manuscript. The corresponding author should certify that all listed authors participated meaningfully in the study and that they have seen and approved the final manuscript. The cover letter must briefly explain each author's individual contributions.


  • MANUSCRIPT PREPERATION GUIDELINE

    The manuscript must be word-processed, and MS Word default typeface and type size are recommended.


    1. Title Page

    The title, each author's full name, position and institutional affiliation(s), and position should be typed on the title page and in the journal style. A running title should be added if a title exceeds 12 words. Capitalize the first letter of nouns and adjectives in the title. Corresponding author's name, E-mail address, and ORCID should be stated. A footnote may be placed.


    2. Abstract

    Authors of original scientific and clinical research papers must supply a structured abstract of no more than 300 words. Briefly state the purpose of the study, methods, primary results, principal conclusions and any clinical implications. Nonstandard abbreviations, references or footnotes should not be used. An unstructured abstract is allowed in the review article, and the clinical case report, with no more than 250 words. At the bottom of the abstract, list of keywords that best describe the content of the study within 6 words. Capitalize the first letter of keywords, listed alphabetically. For the selection of keywords, refer to Medical Subject Heading (MeSH) in PubMed (http://meshb.nlm.nih.gov/search). If suitable MeSH terms are not yet available for recently introduced terms, present terms may be used.


    3. Main text

    1) Original articles
    All clinical research papers submitted which involve human or animal subjects must be accompanied by evidence of IRB or Ethics Committee Review. The body of the text, excluding the abstract, references, tables or illustrations, should not exceed 4,000 words for original research articles. References are limited to those critical and relevant to the manuscript, figure legends, tables, and illustrations. All original manuscripts must include the following:

    • A. Introduction: The rationale for the study should be summarized and pertinent background material outlined. Author may refer to literature, but excessive review is strongly discouraged. The introduction should not contain either results or conclusions.
    • B. Materials and Methods: Methods should be described in sufficient detail so that another investigator could repeat the work. Patient, tested animals and the control group should be stated clearly. The location (manufacturer name, city, state, country) of a manufacturer listed in the text should be included. The authors should describe the generic name, dosage, and administration method of drug and chemical agents used. Ethical guidelines for human or animal study should be described and approval of institutional human research review committee or animal welfare committee should be cited. The statistical analysis and software programs used should be described.
      Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex and/or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex and gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer).
    • C. Results: Results should be presented in logical sequence in the text. Tables and illustrations and repetitive presentation of the same data in different forms should be avoided. The results should not include material appropriate to the discussion.
    • D. Discussion: Discussion should explain results in relation to any hypotheses advanced in the introduction. Indicate the significance of the data and the limitations. Speculate the findings in light of other reports, including opposing views in order to limit bias. Do not repeat the contents of introduction in discussion.
    2) Case reports
    The format should include introduction, case report, and discussion which is similar to that of an original article. The body of the text, excluding the abstract, references, tables or illustrations, should not exceed 2,500 words.
    3) Brief communications
    Brief communications are short articles describing clinical or experimental findings of importance or great advancement. A brief communication should be organized in the same way as case reports and should not exceed 500 words. The number of tables and figures in total should not exceed two.
    4) Letters to the editor
    The journal welcomes readers' comments on articles published recently in the journal or topics of interest.
    5) Reviews
    Substantive reviews of systematic and clinical topics in oral medicine, orofacial pain, dental sleep medicine, geriatric dentistry, and forensic dentistry will be considered for publication. They will both be evaluated by peer review of the manuscript prior to consideration of publication. An abstract must be included.
    6) Editorials
    Editorials express opinions on current topics of interest or provide comments on papers published elsewhere in the same issue. Editorials are usually solicited by the Editor. Tables and/ or figures may be included.
    7) Announcements
    New information in scientific societies and the date of important conference covering topics of relevance of this journal can be announced in this section.


    4. Author contribution

    JOMP follows the recommendations for authorship by the ICMJE, 2013 (http://www.icmje.org/recommendations/). Authorship credit should be based on (1) substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; (2) drafting the work or revising it critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet conditions of 1, 2, 3, and 4.
    The work authors have conducted for the study should be described in this section. To qualify for authorship, all contributors must meet at least one of the 7 core contributions by CRediT (conceptualization, methodology, software, validation, formal analysis, investigation, data curation), as well as at least one of the writing contributions (original draft preparation, review, and editing). Authors may also satisfy the other contributions; however, these alone will not qualify them for authorship. Contributions will be published with the final article and they should accurately reflect contributions to the work. The submitting author is responsible for completing this information at submission, and it is expected that all authors will have reviewed, discussed, and agreed to their individual contributions ahead of this time. The information concerning sources of author contributions should be included in this section at the submission of the final version of the manuscript (at the first submission, this information should be included in the title page). Examples of authors' contributions are as followings: Conceptualization: SJW. Data curation: YH. Formal analysis: ARC. Funding acquisition: SJW. Methodology: SJW, YH, ARC. Project administration: ARC. Visualization: SJW, YH, ARC. Writing – original draft: YH, ARC. Writing – review & editing: SJW, YH, ARC.


    5. Conflict of Interest

    The authors must disclose any potential conflicts of interest possibly influencing the research or interpretation of data at the time of submission. In particular, all sources of funding for a study should be explicitly stated. Statements on conflict of interest have no influence on the editorial decision to publish.


    6. Funding

    Financial support, including foundations, institutions, pharmaceutical and device manufacturers, private companies, or intramural departmental sources, or any other support, should be described.


    7. Acknowledgements

    When necessary, acknowledgements shall be provided for those who contributed to the study in some way that would be insufficient to be considered authors. The acknowledgements should express appreciation for the concrete roles of the contributors in the study (e.g., data collection, statistical processing, and experimental analysis) and the authors should notify these indviduals that their names will be included in the acknowledgements for their consent in advance.
    AI tools in manuscript preparation are required to disclose their use in the acknowledgements section. Such disclosure should detail the specific tools used, including the model name, version, and manufacturer, and explain the capacity in which they were employed. Should the use of AI extend beyond language enhancement, the methods and tools used must be detailed in the Materials and Methods section as a formal part of the research design.


    8. References

    References must be listed and numbered in the order in which they are cited in the text. References should be obviously related to texts and should not exceed 50 in original research article, and 20 in case report. Each reference should be superscripted as [1], [1,4], or [1-3] at the end of the related phrases in the text. List all authors if the number of authors is less than 7. List first 3 authors followed by ‘et al.' if the number of authors is 7 or more. Journal titles are abbreviated in accordance with the style of Index Medicus. For more on references, refer to the National Library of Medicine (NLM) Style Guide for Authors, Editors, and Publishers (http://www.nlm.nih.gov/citingmedicine).


    Reference Style
    • • References to an article with 6 or fewer authors:
      Lee JY, Kho HS, Kim YK, Chung SC, Lee SW. Factors related to patients' satisfaction level of treatment outcome of oral malodor. Korean J Oral Med 2001;26:27-38.
    • • References to an article with more than 6 authors:
      Kim KS, Kim SK, Lee PY, et al. Effects of low incident energy levels of infrared laser irradiation on the proliferation of C. albicans. Part II: a short term study during cell growth. Laser Ther 1995;7:61-66.
    • • References to an article with supplement:
      Lugaresi E, Plazzi G. Heavy snorer disease: from snoring to the sleep apnea syndrome--an overview. Respiration 1997;64(Suppl 1):11-14.
    • • References to an article in press:
      Greaney L, Brennan PA, Kerawala C, Cascarini L, Godden D, Coombes D. Why should I follow up my patients with oral lichen planus and lichenoid reactions? Br J Oral Maxillofac Surg 2014. doi: 10.1016/j.bjoms.2014.01.007. [Epub ahead of print]
    • • Reference to a book:
      Ramfjord SP, Ash MM. Occlusion. 3rd ed. Philadelphia: W.B. Saunders Co.; 1983. pp. 359-365.
    • • Reference to a chapter in a book:
      Birkhed D, Heintze U. Salivary secretion rate, buffer capacity, and pH. In: Tenovuo JO, ed. Human saliva: clinical chemistry and microbiology. Vol. 1. Boca Raton: CRC Press Inc.; 1989. pp. 25-73.
    • • Website:
      World Health Organization (WHO). WHO statistical information system [Internet]. Geneva: WHO; c2010 [cited 2012 Jan 5]. Available from: http://www.who.int/.
    9. Tables

    Each table must be simple and typed on a separate page with its heading above it. JOMP in strongly recommends that the number of tables and figures in total should not exceed 7. Do not embed tables in the body of text. The title of the table should be on top placed. The first letter of the first word should be capitalized. Tables should be numbered consecutively in Arabic numerals beginning with 1. Explanatory matter should be placed in footnotes below the table and should not be included in the heading. All nonstandard abbreviations should be explained in the footnotes. Statistical measures such as SD or SEM should be identified. Vertical rules and horizontal rules between entries should be omitted. Each table should be referred in the text consecutively and numbered according in order of citation. Tables should also be typed double-spaced, including headings. Larger size sheets must not be utilized.


    10. Figures legends

    Figure legends should be written in English on a separate sheet. Do not embed figures in the body of text. Capitalize the first letter of the first word and place a period at the end of the phrase. Figures should be numbered consecutively in Arabic numerals beginning with 1. All abbreviations should be explained as full name in each figure. When symbols, arrows, numbers, or letters are used to identify parts of the photographs and illustrations, identify and explain each one clearly in the legend. If a figure has been previously published, the legend should fully acknowledge the original source.


    11. Figures

    We encourage authors to use color figures when they will enhance the presentation of the data. Only high-resolution figure files (minimum 300 dpi) should be submitted, preferably in JPEG or TIFF format. Adherence to these requirements from the outset will prevent the production editor from contacting the author at a later stage for better quality figures. Scales should be presented as a bar in the picture or as a magnification remark in the legend.
    If any portion of a figure has been previously published, the original source must be acknowledged, and all necessary permissions from the copyright holder to reproduce the material must be obtained.
    Using AI technologies in creating or altering figures, images, and artwork are discouraged unless such use is part of the research design or methods. If authors deem it necessary to use AI tools for these purposes, they must provide a clear description of the content generated, including the name of the tool, version, and manufacturer. This information should accompany the submission. In line with our commitment to maintain the highest ethical standards, we discourage the submission or publication of materials solely created by AI technologies without the necessary human oversight. We hold authors accountable for the integrity of the content generated by these AI models and tools, reiterating that authorship brings with it responsibility for the accuracy, integrity, and originality of the work.


    12. Terminology

    Medical terminology should be followed by the recent terminology book published by the Korean Medical Association (http://term.kma.org/).


    13. Abbreviations

    Abbreviations should be avoided as much as possible, When they are used, full expression of the abbreviation following the abbreviated word in parentheses should be begin at the first use. Do not use abbreviation(s) in the title.


    14. Units of measurement

    Laboratory measurements should be used in SI units (International System of Units). The metric system is preferred for the expression of length, area, mass, and volume.


  • OTHER INFORMATION
    1. Subscription

    For subscription and all other information visit our website available from: http://www.journalomp.org/submission/Login.html. To subscribe to this journal or renew your current subscription, please contact us through Tel (+82-41-550-1913), Fax (+82-41-553-7169) or E-mail (office@journalomp.org). JOMP is an openaccess journal. Every paper published in the journal is available on its website (http://www.journalomp.org) for free. All the articles can be accessed on our website (http://www.journalomp.org). All manuscripts must be submitted online through the website.


    2. Article processing charges

    The authors should pay for publication. The publication related fee is about 300 USD (300,000 KRW). The final charge may be adjusted up to the number of pages and color figures in the article.



Title_page_TemplateEngKor
Body_page_TemplateEngKor
September 2023, 48 (3)